Insmed, Inc. (INSM)
104.85
-32.24
(-23.52%)
USD |
NASDAQ |
May 07, 16:00
108.20
+3.35
(+3.20%)
After-Hours: 20:00
Insmed Research and Development Expense (Annual) : 771.09M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 387.02M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| PTC Therapeutics, Inc. | 455.25M |
| United Therapeutics Corp. | 550.00M |
| Amicus Therapeutics, Inc. | 135.84M |